VanEck Vectors Performance

BBH -- USA Etf  

USD 124.47  0.77  0.61%

The entity has beta of 0.0 which indicates the returns on MARKET and VanEck Vectors are completely uncorrelated. Even though it is essential to pay attention to VanEck Vectors Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. VanEck Vectors Biotech ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
Horizon     30 Days    Login   to change

VanEck Vectors Biotech Relative Risk vs. Return Landscape

If you would invest  12,964  in VanEck Vectors Biotech ETF on September 16, 2018 and sell it today you would lose (517.00)  from holding VanEck Vectors Biotech ETF or give up 3.99% of portfolio value over 30 days. VanEck Vectors Biotech ETF is generating negative expected returns assuming volatility of 1.4061% on return distribution over 30 days investment horizon. In other words, 12% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, VanEck Vectors Biotech ETF is expected to under-perform the market. In addition to that, the company is 1.37 times more volatile than its market benchmark. It trades about -0.12 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.12 per unit of volatility.

VanEck Vectors Market Risk Analysis

Sharpe Ratio = -0.1189
Good Returns
Average Returns
Small Returns
Negative ReturnsBBH

VanEck Vectors Relative Performance Indicators

Estimated Market Risk
  actual daily
 88 %
of total potential
Expected Return
  actual daily
 1 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average VanEck Vectors is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors by adding it to a well-diversified portfolio.

VanEck Vectors Performance Rating

VanEck Vectors Biotech ETF Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Over the last 30 days VanEck Vectors Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions.

VanEck Vectors Alerts

Equity Alerts and Improvement Suggestions

VanEck Vectors generates negative expected return over the last 30 days
The fund holds 98.6% of its assets under management (AUM) in equities

VanEck Vectors Performance Indicators

VanEck Vectors Biotech Basic Price Performance Measures

Fifty Two Week Low111.36
Fifty Two Week High136.84

VanEck Vectors Dividends

VanEck Vectors Biotech Dividends Analysis

Check VanEck Vectors Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.